N-3 polyunsaturated fatty acids in animal models with neuroinflammation: An update

Eur J Pharmacol. 2016 Aug 15:785:187-206. doi: 10.1016/j.ejphar.2015.05.045. Epub 2015 May 30.

Abstract

Neuroinflammation is a characteristic of a multitude of neurological and psychiatric disorders. Modulating inflammatory pathways offers a potential therapeutic target in these disorders. Omega-3 polyunsaturated fatty acids have anti-inflammatory and pro-resolving properties in the periphery, however, their effect on neuroinflammation is less studied. This review summarizes 61 animal studies that tested the effect of omega-3 polyunsaturated fatty acids on neuroinflammatory outcomes in vivo in various models including stroke, spinal cord injury, aging, Alzheimer's disease, Parkinson's disease, lipopolysaccharide and IL-1β injections, diabetes, neuropathic pain, traumatic brain injury, depression, surgically induced cognitive decline, whole body irradiation, amyotrophic lateral sclerosis, N-methyl-D-aspartate-induced excitotoxicity and lupus. The evidence presented in this review suggests anti-neuroinflammatory properties of omega-3 polyunsaturated fatty acids, however, it is not clear by which mechanism omega-3 polyunsaturated fatty acids exert their effect. Future research should aim to isolate the effect of omega-3 polyunsaturated fatty acids on neuroinflammatory signaling in vivo and elucidate the mechanisms underlying these effects.

Keywords: Brain; Cytokines; Docosahexaenoic acid; Microglia; Neuroinflammation; Omega-3 polyunsaturated fatty acids.

Publication types

  • Review

MeSH terms

  • Animals
  • Disease Models, Animal
  • Fatty Acids, Omega-3 / pharmacology*
  • Fatty Acids, Omega-3 / therapeutic use
  • Humans
  • Inflammation / complications
  • Inflammation / drug therapy*
  • Inflammation / metabolism
  • Nervous System Diseases / complications
  • Nervous System Diseases / drug therapy*
  • Nervous System Diseases / metabolism

Substances

  • Fatty Acids, Omega-3